
DEGODE
Degode has recreated a patent-protected prescription drug for the treatment of acne and rosacea (generic drug). It is the first company in the EU to launch this product in co-operation with a well-established pharmaceutical company in initially 10 European countries. The development is completed and the approval phase has begun. Due to a sophisticated formulation which is very close to the original, Degode was able to convince the EU authorities to dispense with the usually long-term and cost-intensive efficacy studies.
This means a significant competitive advantage for Degode. As a result of this unique regulatory study situation, Degode will be the first supplier within the EU
Was sind Generika?
Ein Film des Branchenverbandes ProGenerika
Contact
DEGODE GmbH
Kastanienallee 46
15344 Strausberg
03341 589 9040